CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-22 | Wang Julia Aijun Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +589,888 | 589,888 | ||
| 2022-06-22 | Wu Xiaobin President, COO & GM China | Grant or award | +187,876 | 987,867 | ||
| 2022-06-22 | Wu Xiaobin President, COO & GM China | Grant or award · Share Option (Right to Buy) | +1,061,814 | 1,061,814 | ||
| 2022-06-22 | Dugan Margaret Director | Grant or award | +16,692 | 16,692 | ||
| 2022-06-22 | Dugan Margaret Director | Grant or award · Share Option (Right to Buy) | +34,645 | 34,645 | ||
| 2022-06-22 | Wang Xiaodong Director | Grant or award | +83,499 | 5,806,746 | ||
| 2022-06-22 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +471,913 | 471,913 | ||
| 2022-06-22 | HOOPER ANTHONY C Director | Grant or award | +16,692 | 24,492 | ||
| 2022-06-22 | HOOPER ANTHONY C Director | Grant or award · Share Option (Right to Buy) | +34,645 | 34,645 | ||
| 2022-06-22 | Glazer Donald W. Director | Grant or award | +16,692 | 2,771,221 | ||
| 2022-06-22 | Glazer Donald W. Director | Grant or award · Share Option (Right to Buy) | +34,645 | 34,645 | ||
| 2022-06-22 | Riva Alessandro Director | Grant or award | +16,692 | 16,692 | ||
| 2022-06-22 | Riva Alessandro Director | Grant or award · Share Option (Right to Buy) | +34,645 | 34,645 | ||
| 2022-06-22 | Sanders Corazon (Corsee) D. Director | Grant or award | +16,692 | 24,492 | ||
| 2022-06-22 | Sanders Corazon (Corsee) D. Director | Grant or award · Share Option (Right to Buy) | +34,645 | 34,645 | ||
| 2022-06-22 | Malley Thomas Director | Grant or award | +16,692 | 33,774 | ||
| 2022-06-22 | Malley Thomas Director | Grant or award · Share Option (Right to Buy) | +34,645 | 34,645 | ||
| 2022-06-22 | BAKER BROS. ADVISORS LP Director | Grant or award | +33,384 | 67,569 | ||
| 2022-06-22 | BAKER BROS. ADVISORS LP Director | Grant or award | +33,384 | 67,573 | ||
| 2022-06-22 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +69,290 | 69,290 |
Page 51 of 71 · 1,406 trades